This suggests a possible scenario for progression of iron dysmetabolism in PCa; it involves IRP2 overexpression in differentiated cancer cells as an important moment when a full blown loss of the regulatory mechanisms occurs in cancer cells, which would create a vicious cycle of iron overload and resultant progressive proliferation of cancer cells. The gene discussed is IREB2; the disease is cancer.